乳腺密度、良性乳腺疾病与随时间推移的乳腺癌风险
分析西班牙乳腺癌筛查项目1995-2015年294943名50-69岁女性的个体数据,随访至2017年。中位随访8.0年,3697名(1.25%)诊断乳腺癌,5941名(2.01%)有良性乳腺疾病。良性乳腺疾病和乳腺密度独立增加乳腺癌风险(交互作用P=0.84)。有良性乳腺疾病且乳腺极度致密的女性风险为散在纤维腺体密度且无良性乳腺疾病者的3.07倍(HR=3.07,95%CI 2.01-4.68)。有良性乳腺疾病的女性风险升高持续超过15年,与乳腺密度分类无关。
要点
- 有良性乳腺疾病且乳腺极度致密者乳腺癌风险为散在纤维腺体密度且无良性乳腺疾病者的3.07倍(HR=3.07,95%CI 2.01-4.68)。
- 有良性乳腺疾病者风险升高持续超过15年,与乳腺密度分类无关。
- 良性乳腺疾病与乳腺密度对乳腺癌风险的作用相互独立(交互作用P=0.84)。
核心结论
- 有良性乳腺疾病的女性风险升高持续超过15年,与乳腺密度分类无关;有良性乳腺疾病且乳腺致密的女性未来乳腺癌风险高。
研究设计与样本
- 分析西班牙乳腺癌筛查项目四个地区1995至2015年294943名50-69岁至少参加一次乳腺X线筛查女性的个体数据,随访至2017年。
- 采用部分条件Cox模型评估良性乳腺疾病、乳腺密度与乳腺癌风险之间的关联。
诊断标准与关键数值
- 中位随访8.0年,3697名(1.25%)女性诊断乳腺癌,5941名(2.01%)有良性乳腺疾病。
- 超过一半筛查女性为散在纤维腺体密度(55.0%)。
- 有良性乳腺疾病且乳腺极度致密者相比散在纤维腺体密度且无良性乳腺疾病者乳腺癌风险HR=3.07(95%CI 2.01-4.68)。
- 不均匀致密密度合并良性乳腺疾病者风险接近2.5倍(HR=2.48,95%CI 1.66-3.70)。
- 无良性乳腺疾病的极度致密乳腺者风险增加2.27倍(95%CI 2.07-2.49)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Assessing the combined effect of mammographic density and benign breast disease is of utmost importance to design personalized screening strategies.
METHODS: We analyzed individual-level data from 294,943 women aged 50-69 years with at least one mammographic screening participation in any of four areas of the Spanish Breast Cancer Screening Program from 1995 to 2015, and followed up until 2017. We used partly conditional Cox models to assess the association between benign breast disease, breast density, and the risk of breast cancer.
RESULTS: During a median follow-up of 8.0 years, 3697 (1.25%) women had a breast cancer diagnosis and 5941 (2.01%) had a benign breast disease. More than half of screened women had scattered fibroglandular density (55.0%). The risk of breast cancer independently increased with the presence of benign breast disease and with the increase in breast density (p for interaction = 0.84). Women with benign breast disease and extremely dense breasts had a threefold elevated risk of breast cancer compared with those with scattered fibroglandular density and without benign breast disease (hazard ratio [HR] = 3.07; 95%CI = 2.01-4.68). Heterogeneous density and benign breast disease was associated with nearly a 2.5 elevated risk (HR = 2.48; 95%CI = 1.66-3.70). Those with extremely dense breast without a benign breast disease had a 2.27 increased risk (95%CI = 2.07-2.49).
CONCLUSIONS: Women with benign breast disease had an elevated risk for over 15 years independently of their breast density category. Women with benign breast disease and dense breasts are at high risk for future breast cancer.
KEY POINTS: • Benign breast disease and breast density were independently associated with breast cancer. • Women with benign breast disease had an elevated risk for up to 15 years independently of their mammographic density category.
引用
- Román M, Louro J, Posso M, et al. Breast density, benign breast disease, and risk of breast cancer over time. Eur Radiol. 2021. PMID: 33409776. doi:10.1007/s00330-020-07490-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。